1.56
price down icon2.50%   -0.04
after-market 시간 외 거래: 1.57 0.01 +0.64%
loading

Calcimedica Inc 주식(CALC)의 최신 뉴스

pulisher
Jun 13, 2025

CalciMedica Insiders Added US$1.05m Of Stock To Their Holdings - Yahoo Finance

Jun 13, 2025
pulisher
Jun 12, 2025

CalciMedica's Breakthrough AKI Treatment Takes Center Stage at Prestigious Vicenza Nephrology Conference - Stock Titan

Jun 12, 2025
pulisher
Jun 12, 2025

Millennium Management LLC Acquires 16,824 Shares of CalciMedica, Inc. (NASDAQ:CALC) - Defense World

Jun 12, 2025
pulisher
Jun 06, 2025

calcimedica appoints baker tilly as new accounting firm after merger By Investing.com - Investing.com South Africa

Jun 06, 2025
pulisher
Jun 06, 2025

calcimedica appoints baker tilly as new accounting firm after merger - Investing.com

Jun 06, 2025
pulisher
May 17, 2025

HC Wainwright Reiterates “Buy” Rating for CalciMedica (NASDAQ:CALC) - Defense World

May 17, 2025
pulisher
May 15, 2025

CalciMedica (CALC) Receives Reiteration of Buy Rating with $16 P - GuruFocus

May 15, 2025
pulisher
May 14, 2025

CalciMedica Reports First Quarter 2025 Financial Results and Provides Clinical & Corporate Updates - Citizen Tribune

May 14, 2025
pulisher
May 10, 2025

CalciMedica (CALC) Expected to Announce Quarterly Earnings on Monday - Defense World

May 10, 2025
pulisher
May 09, 2025

CalciMedica Inc expected to post a loss of 31 cents a shareEarnings Preview - TradingView

May 09, 2025
pulisher
May 07, 2025

Renaissance Technologies LLC Purchases New Stake in CalciMedica, Inc. (NASDAQ:CALC) - Defense World

May 07, 2025
pulisher
May 04, 2025

Geode Capital Management LLC Boosts Stock Holdings in CalciMedica, Inc. (NASDAQ:CALC) - Defense World

May 04, 2025
pulisher
Apr 28, 2025

Bristol-Myers Squibb (NYSE:BMY) vs. CalciMedica (NASDAQ:CALC) Critical Review - Defense World

Apr 28, 2025
pulisher
Apr 24, 2025

CalciMedica (NASDAQ:CALC) Shares Up 0.7% – Here’s Why - Defense World

Apr 24, 2025
pulisher
Apr 17, 2025

CalciMedica's Breakthrough Research Takes Center Stage at Two Elite Medical Conferences - Stock Titan

Apr 17, 2025
pulisher
Apr 17, 2025

CalciMedica Announces Presentations at Upcoming Medical Meetings - PR Newswire

Apr 17, 2025
pulisher
Apr 03, 2025

Analysts Offer Predictions for CalciMedica Q4 Earnings - Defense World

Apr 03, 2025
pulisher
Apr 02, 2025

CalciMedica Inc. (CALC) Moves to Buy: Rationale Behind the Upgrade - Yahoo Finance

Apr 02, 2025
pulisher
Apr 02, 2025

Corient Private Wealth LLC Buys New Shares in CalciMedica, Inc. (NASDAQ:CALC) - Defense World

Apr 02, 2025
pulisher
Apr 02, 2025

CalciMedica (NASDAQ:CALC) Receives “Buy” Rating from HC Wainwright - Defense World

Apr 02, 2025
pulisher
Apr 02, 2025

Corient Private Wealth LLC Acquires Shares of 38,000 CalciMedica, Inc. (NASDAQ:CALC) - The AM Reporter

Apr 02, 2025
pulisher
Apr 01, 2025

Graybug Vision stock hits 52-week low at $1.81 - Investing.com India

Apr 01, 2025
pulisher
Apr 01, 2025

Graybug Vision stock hits 52-week low at $1.81 By Investing.com - Investing.com South Africa

Apr 01, 2025
pulisher
Apr 01, 2025

H.C. Wainwright maintains $16 target on CalciMedica stock - Investing.com Australia

Apr 01, 2025
pulisher
Apr 01, 2025

CalciMedica’s Strong Financial Position and Promising Clinical Pipeline Justify Buy Rating - TipRanks

Apr 01, 2025
pulisher
Apr 01, 2025

CalciMedica to Participate in the Jones Healthcare and Technology Innovation Conference - PR Newswire

Apr 01, 2025
pulisher
Mar 27, 2025

CalciMedica says cash sufficient to fund operating plan into mid-2026 - TipRanks

Mar 27, 2025
pulisher
Mar 27, 2025

CALCIMEDICA Earnings Results: $CALC Reports Quarterly Earnings - Nasdaq

Mar 27, 2025
pulisher
Mar 27, 2025

CalciMedica Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Mar 27, 2025
pulisher
Mar 27, 2025

CalciMedica Reports 2024 Financial Results and Provides Clinical & Corporate Updates - Citizen Tribune

Mar 27, 2025
pulisher
Mar 27, 2025

Calcimedica Reports 2024 Financial Results And Provides Clinical & Corporate Updates - MarketScreener

Mar 27, 2025
pulisher
Mar 25, 2025

CalciMedica (CALC) to Release Earnings on Thursday - The AM Reporter

Mar 25, 2025
pulisher
Mar 24, 2025

CalciMedica Inc expected to post a loss of 35 cents a shareEarnings Preview - TradingView

Mar 24, 2025
pulisher
Mar 20, 2025

Atria Investments Inc Buys 7,509 Shares of CalciMedica, Inc. (NASDAQ:CALC) - Defense World

Mar 20, 2025
pulisher
Mar 20, 2025

CalciMedica (CALC) Expected to Announce Quarterly Earnings on Thursday - Defense World

Mar 20, 2025
pulisher
Mar 13, 2025

Graybug Vision stock hits 52-week low at $1.83 amid challenges - Investing.com

Mar 13, 2025
pulisher
Mar 11, 2025

Rani Therapeutics (NASDAQ:RANI) versus CalciMedica (NASDAQ:CALC) Financial Contrast - Defense World

Mar 11, 2025
pulisher
Mar 07, 2025

Promising Phase 2 Results and Market Potential Drive Buy Rating for CalciMedica’s Auxora - TipRanks

Mar 07, 2025
pulisher
Mar 06, 2025

Short Interest in CalciMedica, Inc. (NASDAQ:CALC) Increases By 35.0% - Defense World

Mar 06, 2025
pulisher
Mar 05, 2025

Latham & Watkins Advises CalciMedica in Secured Growth Financing - Latham & Watkins LLP

Mar 05, 2025
pulisher
Mar 05, 2025

CalciMedica secures $32.5 million credit facility By Investing.com - Investing.com Canada

Mar 05, 2025
pulisher
Mar 05, 2025

CalciMedica secures credit facility for up to $32.5M - MSN

Mar 05, 2025
pulisher
Mar 05, 2025

CalciMedica Secures Credit Facility For Up To $32.5 Million -March 05, 2025 at 07:44 am EST - Marketscreener.com

Mar 05, 2025
pulisher
Mar 05, 2025

CalciMedica secures $32.5 million credit facility - Investing.com India

Mar 05, 2025
pulisher
Mar 05, 2025

CalciMedica Secures Credit Facility for Up to $32.5 Million - Finansavisen

Mar 05, 2025
pulisher
Mar 05, 2025

CalciMedica (NASDAQ:CALC) Given “Buy” Rating at HC Wainwright - Defense World

Mar 05, 2025
pulisher
Mar 04, 2025

Graybug Vision stock hits 52-week low at $1.95 amid challenges - Investing.com

Mar 04, 2025
pulisher
Mar 04, 2025

CalciMedica reports reduced mortality in AKI trial with Auxora - Investing.com

Mar 04, 2025
pulisher
Mar 04, 2025

CalciMedica Highlights Auxora’s Potential in COVID-19 Treatment - TipRanks

Mar 04, 2025
pulisher
Mar 04, 2025

CalciMedica reports reduced mortality in AKI trial with Auxora By Investing.com - Investing.com South Africa

Mar 04, 2025
pulisher
Mar 04, 2025

CalciMedica’s Auxora shows mortality reduction in COVID-19 pneumonia trial - TipRanks

Mar 04, 2025
pulisher
Mar 04, 2025

CalciMedica Presents AKI Data from a Post-Hoc Analysis of the Phase 2 CARDEA trial of Auxora™ in Severe COVID-19 Pneumonia at the 30th International AKI & CRRT Conference - PR Newswire

Mar 04, 2025
$20.74
price up icon 0.39%
$35.88
price down icon 0.42%
$21.20
price down icon 0.38%
$97.62
price down icon 3.00%
$107.51
price up icon 0.98%
biotechnology ONC
$245.16
price up icon 1.28%
자본화:     |  볼륨(24시간):